ESR1 and ductal breast carcinoma in situ: We also collected the clinicopathological features of 1,964 patients from 12 Taiwan hospitals (Taiwan cohort) and assessed the relationship between ER status and IBTR in breast DCIS patients who underwent BCS [34].